Literature DB >> 14711064

Obesity and hypertension.

Fadi El-Atat1, Ashish Aneja, Samy Mcfarlane, James Sowers.   

Abstract

This article has discussed some of the mechanisms involved in the causal relation between obesity and hypertension. Obesity causes a constellation of maladaptive disorders that individually and synergistically contribute to hypertension, among other cardiovascular morbidities. Well-designed population-based studies are needed to assess the individual contribution of each of these disorders to the development of hypertension. In addition, because the control of obesity may eliminate 48% of the hypertension in whites and 28% in blacks, this article has offered an up-to-date on the management of this problem. It is hoped that this article will help scientists formulate a thorough understanding of obesity hypertension and form the basis for more research in this field, which has a huge impact on human life.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14711064     DOI: 10.1016/s0889-8529(03)00070-7

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  22 in total

1.  Effort-reward imbalance at work and 5-year changes in blood pressure: the mediating effect of changes in body mass index among 1400 white-collar workers.

Authors:  Xavier Trudel; Chantal Brisson; Alain Milot; Benoit Masse; Michel Vézina
Journal:  Int Arch Occup Environ Health       Date:  2016-07-20       Impact factor: 3.015

2.  Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis.

Authors:  M A Beydoun; H A Beydoun; Y Wang
Journal:  Obes Rev       Date:  2008-03-06       Impact factor: 9.213

3.  The clinical biochemistry of obesity.

Authors:  Ken A Sikaris
Journal:  Clin Biochem Rev       Date:  2004-08

Review 4.  Cardiometabolic syndrome and chronic kidney disease.

Authors:  Guido Lastra; Camila Manrique; Samy I McFarlane; James R Sowers
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

Review 5.  Cardiovascular disease in diabetes and the cardiometabolic syndrome: focus on minority women.

Authors:  John Nicasio; Fadi El-Atat; Samy I McFarlane; Judith H LaRosa
Journal:  Curr Diab Rep       Date:  2005-06       Impact factor: 4.810

Review 6.  Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity.

Authors:  Joseph Fomusi Ndisang
Journal:  Mediators Inflamm       Date:  2010-05-18       Impact factor: 4.711

7.  Plasma lactate and incident hypertension in the atherosclerosis risk in communities study.

Authors:  Stephen P Juraschek; Julie K Bower; Elizabeth Selvin; Ghanshyam Palamaner Subash Shantha; Ron C Hoogeveen; Christie M Ballantyne; J Hunter Young
Journal:  Am J Hypertens       Date:  2014-07-03       Impact factor: 2.689

Review 8.  Treatment of hypertension in metabolic syndrome: implications of recent clinical trials.

Authors:  Amgad N Makaryus; Philippe Akhrass; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2009-06       Impact factor: 4.810

Review 9.  Insulin resistance and blood pressure.

Authors:  Sonya Addison; Sameer Stas; Melvin R Hayden; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2008-08       Impact factor: 5.369

Review 10.  Sudden cardiac death in patients with diabetes.

Authors:  Fadi A El-Atat; Samy I McFarlane; James R Sowers; J Thomas Bigger
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.